Niox Share Discussion Threads

[saadia110] 24/9/2024 08:55

I still can't see it in that RNS for some reason. I guess it must be a date in the future.

[mighunter] 24/9/2024 07:20

There's a separate Tender Offer RNS with the expected timetable of principle events very close to the top

[saadia110] 24/9/2024 07:15

What date is the tender offer date, can't seem to see in RNS.

[jimmywilson612] 24/9/2024 07:01

Well called Earwacks. I've been selling down recently (probably too soon) but this is an excellent update

[earwacks] 24/9/2024 06:45

Boom! 21 percent premium buyback for up to 6 percent existing shareholders holdings. Ever imaganitive ways to return cash. Clear and transparent interims. If only more companies were like this. Probably why it’s half of my portfolio! Pushing to scale up business in USA. All looks pretty good to me

[earwacks] 30/7/2024 08:14

Griffiths the major shareholder has almost halved his position. He and Harwood supplied some shares to Rathbone who now have 5 percent. As has often been said 70p plus was up with events. So I would think this is approaching oversold territory. Quite along way to late September for next update which hopefully would include news about another possible special dividend. Can’t see much action till then, but definitely watching closely for a top simply because it generates cash, and looks pretty solid. Slight disappointment about the time projection for home test kit, but that would be a big catalyst when it happens. Mills say it won’t be spending the cash on acquisition as it just increases risk. Plenty to expand on within. So there is only one alternative to returning it to shareholders and that would be buy backs. I think the big holders would vote for cash return . Short medium and long all look positive whatever the vagaries of the meerkat

[joseph moran] 24/7/2024 11:56

Hope goes up from here, just bought a few more.

[earwacks] 21/7/2024 21:25

Blimey. I think it’s the first time Paul has had anything good to say about one of my stock and GREEN. We are doomed! Of course the balance sheet is brilliant. Tons of cash, and cash generation. Many have doubled their money here already and received a dividend and special. More to come. House broker Singer and others have this as a core holding in their sector. PT raised to 80p. May drift off a bit till September when it becomes clearer about the excess cash, £20-£30 million plus all important £600 million (transferable)tax credit. Not likely to buy anything. More a case of finding a buyer.

[badday] 21/7/2024 18:37

Gets a mention on the Paul Scott podcast ( always worth a listen)
Interesting that he says Christopher Mills due to do Paul Hills (Vox Markets) interview next week.
Christopher Mills was thinking it was fully valued for now, but growing into that value. Might have something to say

Anyway Paul Scott comments below:
“Another interesting company that I've gone green on, which might surprise you, because it's not my usual sort of value share, is a thing called NIOX, N-I-O-X. That put a trading update out. I had another refresh of the figures.

It's quite pricey, but it does something to do with asthma products. And look at the shareholder list on that. You've got Harwood, you've got AstraZeneca, and you've got somebody else who owned about a third of the shares, who were all big name major investors.

So the way I look at it is, they've done the due diligence for us, haven't they? And they obviously think it's good, although... Oh, that was it, Rathbones had bought some shares from the other two big shareholders.

Richard Griffith, I think, was the other one who's got a big position there. He doesn't get everything right, nobody does, but he's certainly a smart cookie. Anyway, so Niox, I think, is worth you having a look at.”

From Small Caps Podcast with Paul Scott: Episode 29 (20 July 2024) - UK Small/Mid Caps with Paul Scott, 20 Jul 2024

This material may be protected by copyright.

[earwacks] 16/7/2024 14:13

Just been reading a rather bizarre report on the med tech sector. Firstly there are some glaring omissions namely COG and Vrci,and having declared the whole sector has underperformed the market while Niox is ‘a very strong hold’ having declared they are over cautious on their forecasts but is up with events! They also reckon there is plenty of room in the cash pile to pay another special dividend of 2.5p. They also have Thermo Fisher (common interest with Vrci) pushing their product in Spain and two bigger concerns doing the same in USA. I still think it was significant that the CFO moved shares into his SIPP in April and transferred shares into his wife's ISA @68p.
Whether it is or not should become apparent in the imminent update. Then there is the by no means not insignificant 600 million tax credit which Chris Mills quite reasonably identified as an asset. Its possible there may have been a blip somewhere but their conservative forecast was ‘inline’ rather than last years ‘ahead’. None the less they still only have a fraction of the market they are in and virtually unopposed. Gl all

[thedudie] 10/7/2024 17:59

Although they have kicked off the home use MyNO development, MyNO appears slated for after 2025 (not sure if that means 2026!)

[badday] 10/7/2024 17:52

Trading update next week hopefully has positive news on distribution into Pharmacies, better impact in US, and maybe something on home use….but that does feel some way off.
Presumably pharmacies could have a quite significant impact on sales fairly quickly, with home use a few years later?

[earwacks] 03/7/2024 14:01

Two buys of £80 and £90 thousand pounds worth of stock and a sale of 756 shares. Which way does the share price go? Answers on a postcard please

[earwacks] 01/7/2024 14:21

Hopefully will be some clues in next update in a couple of weeks. Would like them to have got a bit further with the home test kit, maybe they have. I am surprised if AZN are not interested. They know the company and product , they know the possibilities. Possibly too small?

[edwardt] 01/7/2024 13:58

My guess is this will be sold before Xmas

[thedudie] 01/7/2024 09:05

I doubt AZN would be interested and let's face it they have had plenty of chances. I would think a potential acquirer would approach AZN for the 16% first and then negotiate with management if an agreed takeover is wanted or if another large chunk could be freed up sufficient leverage may be achieved for a hostile takeover.

I am sure it will be bought at some point though as a bolt on business to someone with a similar worldwide footprint.

[earwacks] 01/7/2024 08:30

Interesting appointment with his background and recent activity. I remember back in January they appointed Investec banking as financial advisor and broker, which heightened my curiosity. Investec took a 5 percent holding on June 20th. It has been on the cards that Johnson might repeat the success of his transformation and sale with Bioquel a few years back. I think a lot of people including myself assumed that AZN who hold 16per cent would be the natural candidate, but that came about as a joint venture with Circassia that went wrong but at least netted the 600 million tax credit

[edwardt] 01/7/2024 07:28

New ned knows his way around corporate deal making...

[earwacks] 26/6/2024 12:37

Precisely. And you would do that because? You expect Niox to make a shed load more. And who better to advise you than the CFO! Your hubby

[thedudie] 26/6/2024 12:00

...if you sold £40K of something else that you hold first?

[earwacks] 26/6/2024 11:10

It’s his wife not him. True he could have gifted them to her in the first place. Still going to pay tax on the sale and now sheltering in An ISA to avoid more tax above a gain on 68p. Might have been more significant if she just sold them and not reinvested. How do you get £40k of stock into an ISA in one trade?

[saadia110] 26/6/2024 10:40

I don't know how significant this is as the CFO never bought the shares in the first place. So unless he paid for them they are essentially free shares.

[earwacks] 25/6/2024 21:42

And now the CFO’s wife has transferred 60 k into her ISA. You wouldn’t do that if you thought there wasn’t further to go

[earwacks] 20/6/2024 20:18

And sure enough Rathbone take a chunky 5.2 percent. That’s a confident investment at this stage of the game